Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03586258 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Neuropsychological and Brain Medical Imaging Study in Patients With Brain Damage 2

Study acronym: CORAC2
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. 2 versions Re-verified since Feb 12, 2024, no change to tracked fieldsv8-v9
  2. Primary completion date: Jun 2023 to Jun 2028
    • Study completion date: Jun 2024 to Jun 2030
    v7
  3. 4 versions Re-verified since Jan 22, 2020, no change to tracked fieldsv3-v6
  4. Start date changed from estimate of Jul 2018 to Jan 10, 2019v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University Hospital, Caen
137 trials monitored
See 1 trial at risk
Stroke
3,531 trials monitored
See 153 trials at risk
Two groups of subjects will be constitute: (i) patients with circumscribed brain injury (including stroke, vascular malformations, tumor or circumscribed infectious lesions) or degenerative/developmental disorders and selective cognitive disorders; (ii) healthy control subjects. The objective of this project is to evaluate specific neuropsychological deficits and apply current brain imaging techniques (anatomical, diffusion, functional, magnetic stimulation) to patients suffering from these cognitive deficits due to brain damage, in order to elucidate the brain mechanisms underlying these deficits.
Trial Details
NCT Number NCT03586258
Lead Sponsor University Hospital, Caen
Conditions
(from sponsor)		 Cerebrovascular Disorders, Brain Lesion, Degenerative Disease, Developmental Disability
Related terms Cerebrovascular Disorders, Developmental Disabilities
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov